A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers

NCT05851066 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias
Familial Hypercholesterolemia
Hypertriglyceridemia

Interventions

DRUG: VSA003
DRUG: 0.9% NaCl

Sponsor

Visirna Therapeutics HK Limited